Title : List of adverse effects of pazopanib
Text : This is a list of adverse effects of the anti-cancer drug [[pazopanib]], sorted by frequency of occurrence.<ref name = MSR>{{cite web|title=Votrient (pazopanib) dosing, indications, interactions, adverse effects, and more|work=Medscape Reference|publisher=WebMD|accessdate=27 January 2014|url=http://reference.medscape.com/drug/votrient-pazopanib-999306#showall}}</ref><ref name = DM>{{cite web|title=VOTRIENT (pazopanib hydrochloride) tablet, film coated |work=DailyMed|publisher=GlaxoSmithKline LLC|date=November 2013|accessdate=27 January 2014|url=http://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553&type=pdf&name=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553|format=PDF}}</ref><ref name = EMA>{{cite web|title=Votrient : EPAR - Product Information|work=European Medicines Agency|publisher=Glaxo Group Ltd.|date=23 January 2014|accessdate=27 January 2014|url=http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001141/WC500094272.pdf|format=PDF}}</ref><ref name = EMC>{{cite web|title=Votrient 200 mg and 400 mg film coated tablets - Summary of Product Characteristics (SPC)|work=electronic Medicines Compendium|publisher=GlaxoSmithKline UK|date=20 December 2013|accessdate=27 January 2014|url=http://www.medicines.org.uk/emc/medicine/23148/SPC/Votrient+200+mg+and+400+mg+film+coated+tablets/}}</ref><ref name = TGA>{{cite web|title=PRODUCT INFORMATION VOTRIENT® TABLETS|work=TGA eBusiness Services|publisher=GlaxoSmithKline Australia Pty Ltd|date=25 March 2013|accessdate=27 January 2014|url=https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-07077-3|format=PDF}}</ref>

==Very common==
Very common (>10% incidence) adverse effects include:
{{div col|colwidth=18em}}
* Reduced appetite
* Headache
* [[Dysgeusia|Taste changes]]
* [[Hypertension|High blood pressure]]<ref group = Note>Usually occurs within the first 18 weeks of treatment. 39% of cases develop within the first 9 days of treatment.</ref>
* Diarrhoea
* Abdominal pain
* Nausea
* Vomiting
* Hair colour change
* [[Hand-foot syndrome]]
* [[Alopecia|Hair loss]]
* Rash
* Fatigue
* Increased [[alanine aminotransferase]]
* Increased [[aspartate aminotransferase]]
* Tumour pain<sup>‡</sup>
* Myelosuppression<sup>‡</sup><ref group = Note>This includes leucopenia, thrombocytopenia and neutropenia.</ref>
* Stomatitis<sup>‡</sup>
* Exfoliative rash<sup>‡</sup>
* Skin hyperpigmentation<sup>‡</sup>
* Weight loss<sup>‡</sup>
{{div col end}}

==Common==
Common (1–10% incidence) adverse effects include:
{{div col|colwidth=18em}}
* Tumour pain<sup>†</sup>
* Myelosuppression<sup>†</sup><ref group = Note>This includes leucopenia, lymphopenia, thrombocytopenia and neutropenia.</ref>
* [[Hypothyroidism|Underactive thyroid]]
* Dehydration
* [[Hypophosphataemia|Low level of phosphate in the blood]]
* Dizziness
* Lethargy
* [[Paraesthesia]]
* Peripheral sensory neuropathy
* Blurred vision
* Hot flush
* Venous thromboembolic event
* Flushing
* [[Epistaxis|Nose bleed]]
* [[Dysphonia|Voice anomalies]]
* [[Dyspnoea|Shortness of breath]]
* [[Haemoptysis|Coughing up blood]]
* [[Stomatitis]]
* [[Dyspepsia|Indigestion]]
* [[Flatulence]]
* Abdominal distension
* Dry mouth
* Mouth ulceration
* Hyperbilirubinaemia
* Abnormal liver function
* Hepatotoxicity
* Skin hypopigmentation
* Dry skin
* [[Pruritus|Itchiness]]
* [[Erythema]]
* Skin depigmentation
* [[Hyperhidrosis]]
* [[Arthralgia|Joint pain]]
* [[Myalgia|Muscle aches]]
* Muscle spasms
* [[Proteinuria|Protein in the urine]]
* Mucosal inflammation
* [[Asthenia|Weakness]]
* [[Oedema]]
* Chest pain
* Weight loss<sup>†</sup>
* Increased blood [[creatinine]]
* [[Lipase]] increased
* Decreased white blood cell count
* Blood [[Thyroid stimulating hormone|TSH]] decreased
* [[Amylase]] increased
* [[Gamma-glutamyltransferase]] increased
* Increased blood pressure
* Increased blood [[urea]]
* Abnormal liver function test
* Gingival infection<sup>‡</sup>
* Dizziness
* Insomnia
* Peripheral sensory neuropathy
* Heart dysfunction
* Blurred vision
* [[Bradycardia|Low heart rate]]
* Left ventricular dysfunction
* Bleeding (including haemorrhage)
* [[Hyperglycaemia|High blood sugar]]
* [[Hypoglycaemia|Low blood sugar]]
{{div col end}}

==Uncommon==
Uncommon (0.1–1% incidence) adverse effects include:
{{div col|colwidth=18em}}
* [[Torsades de pointes]]
* Heart failure
* Liver failure
* GI perforation (may be fatal)
* Fistula formation
{{div col end}}

==Rare==
Rare (<0.1% incidence) adverse effects include:
* Reversible posterior leucoencephalopathy syndrome

==Notes==
<sup>†</sup> Denotes side effects seen at the above frequency only in clinical trials performed in people with [[renal cell carcinoma]].

<sup>‡</sup> Denotes side effects seen at the above frequency only in clinical trials done in people with [[soft tissue sarcoma]]s.

{{reflist|group = Note}}

==References==
{{reflist|2}}

[[Category:Medication side effects|Pazopanib]]
